🚀 VC round data is live in beta, check it out!
Voxel Valuation Multiples
Discover revenue and EBITDA valuation multiples for Voxel and similar public comparables like NIOX Group, Australian Clinical Labs, Healius, Atrys Health and more.
Voxel Overview
About Voxel
Voxel SA is a network of diagnostic imaging laboratories created for patients and to increase access to high-quality tests. The company operates diagnostic imaging centers and laboratories and provides several services such as magnetic resonance imaging, computed tomography and positron emission tomography. It has 33 specialised laboratories in 21 cities throughout Poland.
Founded
2005
HQ
Employees
396
Website
Financials (LTM)
EV
$367M
Voxel Financials
Voxel reported last 12-month revenue of $168M and EBITDA of $55M.
In the same LTM period, Voxel generated $55M in EBITDA and $30M in net income.
Revenue (LTM)
Voxel P&L
In the most recent fiscal year, Voxel reported revenue of $163M and EBITDA of $53M.
Voxel expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $168M | XXX | $163M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $47M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA | $55M | XXX | $53M | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 23% | XXX | XXX | XXX |
| Net Profit | $30M | XXX | $29M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| Net Debt | — | — | $12M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Voxel Stock Performance
Voxel has current market cap of $319M, and enterprise value of $367M.
Market Cap Evolution
Voxel's stock price is $30.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $367M | $319M | 0.1% | XXX | XXX | XXX | $2.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVoxel Valuation Multiples
Voxel trades at 2.2x EV/Revenue multiple, and 6.7x EV/EBITDA.
EV / Revenue (LTM)
Voxel Financial Valuation Multiples
As of April 20, 2026, Voxel has market cap of $319M and EV of $367M.
Equity research analysts estimate Voxel's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Voxel has a P/E ratio of 10.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $319M | XXX | $319M | XXX | XXX | XXX |
| EV (current) | $367M | XXX | $367M | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | 6.7x | XXX | 7.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 9.8x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 7.8x | XXX | XXX | XXX |
| P/E | 10.5x | XXX | 11.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 32.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Voxel Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Voxel Margins & Growth Rates
Voxel's revenue in the last 12 month grew by 13%.
Voxel's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.0M for the same period.
Voxel's rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Voxel's rule of X is 74% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Voxel Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | 15% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 49% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 74% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 6% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Voxel Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Voxel | XXX | XXX | XXX | XXX | XXX | XXX |
| NIOX Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioneer | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Voxel M&A Activity
Voxel acquired XXX companies to date.
Last acquisition by Voxel was on XXXXXXXX, XXXXX. Voxel acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Voxel
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVoxel Investment Activity
Voxel invested in XXX companies to date.
Voxel made its latest investment on XXXXXXXX, XXXXX. Voxel invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Voxel
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Voxel
| When was Voxel founded? | Voxel was founded in 2005. |
| Where is Voxel headquartered? | Voxel is headquartered in Poland. |
| How many employees does Voxel have? | As of today, Voxel has over 396 employees. |
| Is Voxel publicly listed? | Yes, Voxel is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Voxel? | Voxel trades under VOX ticker. |
| When did Voxel go public? | Voxel went public in 2011. |
| Who are competitors of Voxel? | Voxel main competitors are NIOX Group, Australian Clinical Labs, Healius, Atrys Health. |
| What is the current market cap of Voxel? | Voxel's current market cap is $319M. |
| What is the current revenue of Voxel? | Voxel's last 12 months revenue is $168M. |
| What is the current revenue growth of Voxel? | Voxel revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Voxel? | Current revenue multiple of Voxel is 2.2x. |
| Is Voxel profitable? | Yes, Voxel is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Voxel? | Voxel's last 12 months EBITDA is $55M. |
| What is Voxel's EBITDA margin? | Voxel's last 12 months EBITDA margin is 33%. |
| What is the current EV/EBITDA multiple of Voxel? | Current EBITDA multiple of Voxel is 6.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.